ModelEdge

TherapeuticsMD
TXMD
Filing Type10-K/A
Filing Date3/31/2026
Updated3/31/26, 7:53 PM

Filing

10-K/A
Earnings Release

Exhibits

10-K/AAmended Annual Report
EX-23.1CONSENT OF BERKOWITZ POLLACK BRANT
EX-23.2CONSENT OF CARR, RIGGS & INGRAM, L.L.C.
EX-31.1CERTIFICATION OF CHIEF EXECUTIVE OFFICER
EX-31.2CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
EX-32.1SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
EX-32.2SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic